Search...
PMV Pharmaceuticals (PMVP) Receives a Buy from Craig-Hallum
I'm PortAI, I can summarize articles.
Albert Lowe from Craig-Hallum maintains a Buy rating on PMV Pharmaceuticals (PMVP) with a $4.00 price target. Lowe, who covers the Healthcare sector, has an average return of 25.8% and a 56.92% success rate. PMV Pharmaceuticals has a Strong Buy consensus with a $5.00 price target.
In a report released today, Albert Lowe from Craig-Hallum maintained a Buy rating on PMV Pharmaceuticals, with a price target of $4.00.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Lowe covers the Healthcare sector, focusing on stocks such as Rezolute, Atossa Therapeutics, and Eledon Pharmaceuticals. According to TipRanks, Lowe has an average return of 25.8% and a 56.92% success rate on recommended stocks.
PMV Pharmaceuticals has an analyst consensus of Strong Buy, with a price target consensus of $5.00.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments